ASP list receives 1.39% lift; Albuterol drops more than 10%

Why This Topic Matters

Quarterly ASP updates affect reimbursement for physician-administered drugs under Medicare Part B and can influence claim review, budgeting, and revenue planning. Understanding which drugs changed most helps practices monitor payment shifts and related billing impact.

Article Sections

1. Overview of second-quarter ASP changes

   Summarizes the overall movement in the Medicare Part B average sales price list for the quarter and notes how the update compares with the prior quarter.

2. Largest increases and decreases

   Highlights the drugs with the most notable upward and downward payment changes and discusses the general market context described in the article.

3. Key ASP changes for Part B drugs for second quarter 2009

   Presents a table of notable payment increases and decreases for selected physician-administered drugs in the second quarter update.